^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    PDC*lung

    i
    Associations
    News

    Trials

    Company:
    LG Chem, PDC line Pharma
    Drug class:
    MUC1 inhibitor, MAGE-A4 inhibitor, NY ESO 1 inhibitor, Survivin inhibitor, MAGE-A3 inhibitor, Melanoma cell surface antigen inhibitor, Multi-MAGE inhibitor
    Related drugs:
    Associations
    News

    Trials

    Apply
    Safety, Immunogenicity and Preliminary Clinical Activity Study of PDC*lung01 Cancer Vaccine in NSCLC (PDC-LUNG-101) (NCT03970746)
    Phase 1/2
    PDC*line Pharma SAS
    Active, not recruiting
    Last update posted :
    10/24/2023
    Initiation :
    09/10/2019
    Primary completion :
    12/01/2025
    Completion :
    12/01/2025
    CD8 • HLA-A
    |
    HLA-A*02
    |
    Keytruda (pembrolizumab) • pemetrexed • PDC*lung